换一批Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.
第一作者：
C,Wihler
第一单位：
Therapeutic Department Cardiovascular, Aventis Pharma Deutschland GmbH, 65926 Frankfurt am Main, Germany.
作者：
医学主题词
血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);动物(Animals);抗坏血酸(Ascorbic Acid);血糖(Blood Glucose);色谱法, 高压液相(Chromatography, High Pressure Liquid);肌酸(Creatine);脱氧葡萄糖(Deoxyglucose);糖尿病, 2型(Diabetes Mellitus, Type 2);糖尿病肾病(Diabetic Nephropathies);杂环化合物, 3环(Heterocyclic Compounds, 3-Ring);肾(Kidney);赖氨酸(Lysine);男(雄)性(Male);氧化还原(Oxidation-Reduction);蛋白酶抑制药(Protease Inhibitors);雷米普利(Ramipril);大鼠(Rats);大鼠, Zucker(Rats, Zucker);光谱法, 荧光(Spectrometry, Fluorescence)
DOI
10.1007/s00125-005-1837-9
PMID
16010524
发布时间
2022-12-07
- 浏览61
Diabetologia
1645-53页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
